Bruker appoints diagnostics industry veteran Jack Phillips to board, effective Jan 2026

BRUKER CORP

Jack Phillips appointed to Bruker board effective Jan 1, 2026, filling newly created 11th director seat.
Phillips previously President & CEO of Accelerate Diagnostics (2020-25) and Roche Diagnostics North America (2010-20).
CEO Laukien says addition is timely as Bruker broadens infectious disease diagnostics portfolio.
Phillips will serve until 2027 Annual Meeting; compensation consistent with other non-employee directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.